Literature DB >> 31090857

Multiple organ dysfunction - we must take a closer look at muscle wasting!

Cassiano Teixeira1,2, Felippe Leopoldo Dexheimer Neto3, Régis Goulart Rosa1.   

Abstract

Entities:  

Year:  2019        PMID： 31090857      PMCID： PMC6649226          DOI： 10.5935/0103-507X.20190021

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN： 0103-507X


× No keyword cloud information.
  5 in total

1.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

2.  Functional Status in ICU Survivors and Out of Hospital Outcomes: A Cohort Study.

Authors:  Jessica E Rydingsward; Clare M Horkan; Kris M Mogensen; Sadeq A Quraishi; Karin Amrein; Kenneth B Christopher
Journal:  Crit Care Med       Date:  2016-05       Impact factor: 7.598

3.  Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors.

Authors:  Victor D Dinglas; Lisa Aronson Friedman; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl B Shanholtz; Nancy D Ciesla; Peter J Pronovost; Dale M Needham
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 4.  Multiple Organ Dysfunction: The Defining Syndrome of Sepsis.

Authors:  Markus T Ziesmann; John C Marshall
Journal:  Surg Infect (Larchmt)       Date:  2018-01-23       Impact factor: 2.150

Review 5.  Clinical review: intensive care unit acquired weakness.

Authors:  Greet Hermans; Greet Van den Berghe
Journal:  Crit Care       Date:  2015-08-05       Impact factor: 9.097
  5 in total
  1 in total

1.  Paeoniflorin Ameliorates Skeletal Muscle Atrophy in Chronic Kidney Disease via AMPK/SIRT1/PGC-1α-Mediated Oxidative Stress and Mitochondrial Dysfunction.

Authors:  Qiang Li; Jing Wu; Jiawen Huang; Rong Hu; Haiyan You; Lingyu Liu; Dongtao Wang; Lianbo Wei
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.